Spinal Bupivacaine Dosing for Same-Day Discharge Anterior Total Hip Arthroplasty
For same-day discharge anterior total hip arthroplasty, you should use 7.5 mg of hyperbaric bupivacaine (or consider switching to mepivacaine 37.5-52.5 mg for even faster recovery), as lower doses of bupivacaine enable earlier ambulation while maintaining adequate surgical anesthesia.
Evidence-Based Rationale
The PROSPECT guidelines 1 recommend spinal or general anesthesia for total hip arthroplasty, with intrathecal morphine 0.1 mg as an optional adjunct when spinal is used. However, these guidelines do not specifically address dose optimization for same-day discharge protocols.
Bupivacaine Dosing Strategy
Low-dose bupivacaine (7.5-10 mg) is the appropriate choice when using bupivacaine for same-day discharge:
A study comparing bupivacaine doses in elderly THA patients demonstrated that 7.5 mg of 0.5% bupivacaine with 20 μg fentanyl provided adequate surgical anesthesia with better hemodynamic stability and longer postoperative analgesia compared to 10 mg bupivacaine alone 2
The ED50 for isobaric bupivacaine in hip replacement surgery is 7.1 mg (95% CI: 6.0-8.4 mg), with ED95 at 12.3 mg 3. This suggests that doses in the 7.5-9 mg range should provide adequate anesthesia for most patients
FDA labeling 4 indicates standard doses of 10-20 mL of 0.5% bupivacaine (50-100 mg) for epidural use, but intrathecal dosing requires much lower amounts
Superior Alternative: Mepivacaine
The strongest recent evidence supports switching from bupivacaine to mepivacaine for same-day discharge:
A 2020 randomized trial demonstrated that 52.5 mg mepivacaine enabled 70% of patients to ambulate at 3-3.5 hours post-surgery, compared to only 37.7% with 11.25 mg hyperbaric bupivacaine and 17.6% with 12.5 mg isobaric bupivacaine 5. Same-day discharge rates were 46% with mepivacaine versus 24.5% and 21.5% with the bupivacaine formulations (P=0.014)
A 2024 quality improvement study confirmed that switching from hyperbaric bupivacaine 9-10.5 mg to isobaric mepivacaine 37.5-45 mg reduced PACU length of stay from 5.33 to 4.03 hours (P=0.008) 6
A 2025 study using 51 mg hypobaric mepivacaine showed motor function return by 145 minutes versus 217 minutes with 10 mg hypobaric bupivacaine 7
Clinical Algorithm
If using bupivacaine:
- Dose: 7.5-9 mg of hyperbaric 0.5% bupivacaine (1.5-1.8 mL)
- Consider adding fentanyl 20 μg to reduce required bupivacaine dose and improve hemodynamic stability 2
- Expect motor block resolution by approximately 3.5-4 hours
If able to use mepivacaine (preferred for same-day discharge):
- Dose: 37.5-52.5 mg (2.5-3.5 mL of 1.5% solution)
- Expect motor block resolution by approximately 2.5 hours
- Accept higher early postoperative pain scores and opioid requirements as trade-off for faster discharge 5, 6
Important Caveats
Avoid higher bupivacaine doses: The FDA label 4 warns against using 0.75% bupivacaine for obstetrical anesthesia due to cardiac toxicity risk, and standard epidural doses (50-150 mg) are far too high for intrathecal use in same-day discharge protocols.
Trade-offs with shorter-acting agents: Mepivacaine patients experience higher pain scores (mean VAS 6.29 vs 3.41) and greater opioid consumption (22.5 vs 11.4 mg OMME) in the immediate postoperative period 6, but this resolves quickly and enables faster discharge.
Isobaric versus hyperbaric formulations: Isobaric bupivacaine at 12.5 mg produces the longest motor block (only 17.6% ambulating at 3-3.5 hours) 5, making hyperbaric formulations preferable if bupivacaine must be used.
Adjunct analgesia is essential: The PROSPECT guidelines 1 emphasize that regardless of spinal technique, patients require paracetamol, NSAIDs/COX-2 inhibitors, dexamethasone 8-10 mg IV, and either fascia iliaca block or local infiltration analgesia to optimize same-day discharge success.